0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Jan 20, 2017 - FDA Drug Updates

Approval of Trulance (plecanatide) for chronic idiopathic constipation

FDA approved Trulance (plecanatide) for chronic idiopathic constipation in adults

Read more
  • Jan 18, 2017 - MedWatch Drug Updates

ED-3490TK video duodenoscope by Pentax – Recommendations update to prevent patient infection

FDA provides important update about a design issue with the PENTAX ED-3490TK duodenoscope to prevent risk of patient infections

Read more
  • Jan 16, 2017 - MedWatch Drug Updates

Fujifilm Medical Systems has removed certain older duodenoscope models

Fujifilm Medical Systems has replaced 250/450 duodenoscope models with the ED-530XT model

Read more
  • Jan 13, 2017 - MedWatch Drug Updates

FDA urges not to use PNC products for cancer treatment due to microbial contamination

FDA warns cancer patients not to use PNC products for treatment due to possible microbial contamination

Read more
  • Dec 27, 2016 - FDA Drug Updates

First drug approved for treatment of spinal muscular atrophy

FDA approved Spinraza (nusinersen) to address the unmet medical need for spinal muscular atrophy

Read more
  • Jan 12, 2017 - MedWatch Drug Updates

Implantable infusion pumps – FDA alerts about important safety precautions

FDA warns about severe adverse events associated with the use implantable infusion pumps

Read more
  • Jan 11, 2017 - MedWatch Drug Updates

Implantable cardiac devices and Merlin transmitter - Cybersecurity vulnerabilities have been reported

Cybersecurity vulnerabilities have been reported in implantable cardiac devices and Merlin transmitter by St. Jude Medical

Read more
  • Dec 20, 2016 - FDA Drug Updates

FDA approved Rubraca (rucaparib) for BRCA+ advanced ovarian cancer

FDA approved Rubraca (rucaparib), a poly ADP-ribose polymerase (PARP) inhibitor for the treatment of BRCA+ advanced ovarian cancer

Read more
  • Dec 15, 2016 - FDA Drug Updates

FDA approved Eucrisa (crisaborole) for atopic dermatitis

FDA approved Eucrisa (crisaborole) for treatment of mild to moderate eczema

Read more
  • Nov 24, 2016 - FDA Drug Updates

FDA approved Soliqua 100/33 (insulin glargine and lixisenatide) for type II diabetes

FDA approved once-daily Soliqua 100/33 (insulin glargine & lixisenatide) inj by Sanofi for treatment of adults with type 2 diabetes

Read more